Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
A Study of MLN9708 in Japanese Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM)
ClinicalTrials.gov study NCT04272775. IPD Sharing: YES. Countries: 0. Publications: 0.
First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM)
ClinicalTrials.gov study NCT04083534. IPD Sharing: YES. Countries: 1. Publications: 0.
Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency
ClinicalTrials.gov study NCT01337752. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Observation of the Efficacy of BAd Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05006469. IPD Sharing: NO. Countries: 1. Publications: 0.
SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma
ClinicalTrials.gov study NCT03589222. IPD Sharing: NO. Countries: 1. Publications: 0.
Biomechanical and Metabolic Assessment Pre and Post Vertebroplasty in Multiple Myeloma Patients With Vertebral Collapse
ClinicalTrials.gov study NCT06255639. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
ClinicalTrials.gov study NCT06582017. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma
ClinicalTrials.gov study NCT00012350. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Temsirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00079456. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT05123131. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00313625. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose Escalation Study of MLN0128 in Relapsed or Refractory Multiple Myeloma or Waldenstrom Macroglobulinemia
ClinicalTrials.gov study NCT01118689. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple Myeloma
ClinicalTrials.gov study NCT03700450. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Aut
ClinicalTrials.gov study NCT05243797. IPD Sharing: Not stated. Countries: 25. Publications: 0.
Metformin, Nelfinavir, and Bortezomib in Treating Patients With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03829020. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of Imexon for Treatment of Multiple Myeloma Patients
ClinicalTrials.gov study NCT00327249. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05675449. IPD Sharing: NO. Countries: 2. Publications: 0.
Anonymization of Clinical Data From Pseudonymized Databases Collected as Part of Previus Clinical Trials on Multiple Myeloma
ClinicalTrials.gov study NCT07283224. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma
ClinicalTrials.gov study NCT00482846. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
ClinicalTrials.gov study NCT04939142. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.